Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery.

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

The finish line for this year’s AI sprint is Las Vegas in December, when Garman will host his first full re:Invent conference as chief executive. He promises a “lot of agentic news” and hints at ...

Internet Matters warned that youngsters and parents are 'flying blind', lacking 'information or protective tools' to manage ...

Apple Offers as Much as $150 Million for Formula One U.S. Rights The bid puts F1 on track for a significantly more lucrative deal than it has with its current partner, Disney's ESPN. The company's ...

Tasked with bringing back advertising dollars to a platform whose owner had told brands who did not spend with them to “go f- ...

Linda Yaccarino didn’t lose her job. She was boxed out of it. That’s the view now flooding the ad world after the former ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

Apple's iPhone 17e is anticipated to be the successor to the iPhone 16e, which made its debut in February 2025.